Recurrent or Refractory Solid Tumors
2 clinical trials · Condition
◉ Watch Recurrent or Refractory Solid Tumors
| Record | Firm | Date |
|---|---|---|
| Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors (NCT02013336) | South Plains Oncology Consortium | 2013-12-01 |
| A Trial of Everolimus and Bevacizumab in Children With Recurrent Solid Tumors (NCT00756340) | St. Jude Children's Research Hospital | 2008-07-01 |
Track Recurrent or Refractory Solid Tumors automatically
Every clearance here is in the API, with alerts when new ones post.